The WACC of Celldex Therapeutics Inc (CLDX) is 7.0%.
Range | Selected | |
Cost of equity | 8.10% - 12.70% | 10.40% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 5.9% - 8.2% | 7.0% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.92 | 1.4 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 8.10% | 12.70% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 5.9% | 8.2% |
Selected WACC | 7.0% | |